RecruitingNCT03450005

ECMM Candida Registry - CandiReg


Sponsor

University of Cologne

Enrollment

2,000 participants

Start Date

Jan 18, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of the European Confederation of Medical Mycology - ECMM Candida Registry (CandiReg) is to overcome the lack of knowledge on epidemiology, clinical course, and molecular characteristics of invasive infections due to invasive Candida infections and to function as a platform for future studies and in case of outbreaks.


Eligibility

Inclusion Criteria6

  • Cultural, histopathological, antigen or DNA evidence of invasive fungal infection with Candida species.
  • Hepatosplenic candidiasis with signs of disseminated Candida infection without culture, histological or microscopic evidence
  • Case control
  • Matching procedure for controls:
  • In part, controls will be included at the same hospitals that include cases (i.e. each one control per case, both in the same hospital).
  • Controls will be matched by demographics, underlying diseases and risk factors as well as duration of hospitalization

Exclusion Criteria1

  • \- Colonization or other non-invasive infection, including superficial skin infections, candiduria without dissemination or Candida spp. in stool.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital Cologne

Cologne, North Rhine-Westphalia, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03450005


Related Trials